晚期恶性肿瘤患者多伴有食欲不振、恶心、进食量少及体重下降等症状 ,直接影响到姑息性放疗的完成。我科在1999年对 5 2例接受姑息放疗的晚期恶性肿瘤患者 ,选择32例在放疗同时口服甲孕酮 (治疗组 )。 2 0例单纯放疗 (对照组 )。结果发现甲孕酮对改善晚期恶性肿瘤患者的生活质 Patients with advanced malignant tumors often suffer from loss of appetite, nausea, low intake of food, and weight loss, which directly affect the completion of palliative radiotherapy. In 1999, 52 patients with advanced malignant tumor receiving palliative radiotherapy were selected by our department. 32 patients were treated with oral medroxyprogesterone (treatment group) at the same time. Twenty patients received radiotherapy alone (control group). Findings that medroxyprogesterone improves quality of life in patients with advanced malignant tumors